28 Jul 2021 Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017 Member news
27 Jul 2021 eTheRNA immunotherapies appoints Mathieu Lane as Chief Financial Officer and President of eTheRNA Inc. located in the U.S.A Member news
15 Jul 2021 Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands Member news
15 Jul 2021 ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments Member news
15 Jul 2021 Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study Member news
15 Jul 2021 Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation Member news
13 Jul 2021 eTheRNA immunotherapies and Ghent University announce mRNA Delivery Collaboration and License Agreement Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
